Latest Partnerships News

Gold Hydrogen Limited has closed a $14.5 million strategic investment round led by Toyota, Mitsubishi Gas Chemical, and ENEOS Xplora, positioning the company to accelerate drilling and commercialisation efforts at its Ramsay Project in South Australia.

Alliance Nickel has appointed financial advisors to explore a SPAC transaction for a Nasdaq listing, aiming to tap into premium US capital markets for its NiWest Nickel-Cobalt Project. The move follows a robust feasibility study and a strategic partnership with automaker Stellantis.

Liontown Resources reported a robust September quarter, doubling underground ore output and strengthening its balance sheet to $420 million. The company’s FY26 guidance confirms a strategic shift to underground mining with anticipated cost improvements.

Zeotech Limited has locked in a $204 million binding offtake agreement for its kaolin products and successfully demonstrated its AusPozz™ low-carbon metakaolin in a large-scale concrete pour, signaling strong momentum in its commercialisation efforts.

Breakthrough Minerals reports encouraging soil sampling results at its Errolls Gold Project in Western Australia, setting the stage for imminent reverse circulation drilling. The company maintains a solid cash position of approximately AUD 1.68 million to support exploration activities.

The Calmer Co has reported a robust 26% increase in quarterly sales, driven by strong growth in Australia and the US, alongside a significant 39% reduction in cash used in operations, signaling clear progress toward profitability.

Syrah Resources reported resumed production at its Balama graphite mine and ongoing qualification delays at its Vidalia anode material facility, while US tariffs on Chinese graphite reshape global supply chains.

The Calmer Co. International Limited has delivered its strongest quarter yet, with revenue surging 26% to $2.4 million and operating cash outflows dropping to a historic low. Strategic growth across retail, e-commerce, and B2B channels underpins its confident path to breakeven.

Microba Life Sciences reports robust Q1 FY26 growth in microbiome diagnostics, introduces workflow-enhancing features, and prepares for key therapeutic deal catalysts by year-end.

IODM Limited has reported a record-breaking first quarter for FY26, with cash receipts soaring 76% year-on-year, driven predominantly by explosive growth in its UK Education segment. The company also made strategic advances in North America and Japan, setting the stage for broader global expansion.

Microba Life Sciences reports a 145% jump in core microbiome test volumes and is on track to achieve regional break-even by FY26, supported by strategic cost cuts and a $14.5 million capital raise.

X2M Connect Limited kicks off FY26 with a 25% revenue surge and a significant reduction in net debt, backed by major new contracts across Asia and the Middle East.